Cargando…
Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study
Background: Drug resistant-tuberculosis (DR-TB) patients are provided universal drug susceptibility testing (UDST), anti-TB drugs for the treatment of DR-TB, nutritional support (Nikshay Poshan Yojana - the financial incentive of rupees five hundred per month for each notified DR-TB patient for the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982631/ https://www.ncbi.nlm.nih.gov/pubmed/35399462 http://dx.doi.org/10.7759/cureus.22886 |
_version_ | 1784681844123369472 |
---|---|
author | Giri, Om P Kumar, Abhay Giri, Vishal P Nikhil, Nishant |
author_facet | Giri, Om P Kumar, Abhay Giri, Vishal P Nikhil, Nishant |
author_sort | Giri, Om P |
collection | PubMed |
description | Background: Drug resistant-tuberculosis (DR-TB) patients are provided universal drug susceptibility testing (UDST), anti-TB drugs for the treatment of DR-TB, nutritional support (Nikshay Poshan Yojana - the financial incentive of rupees five hundred per month for each notified DR-TB patient for the duration for which the patient is on anti-TB drugs) by the Government of India. Methods: This retrospective cohort record-based study was conducted in DR-TB patients. Some 1095 DR-TB patients who have initiated treatment at Nodal DR-TB Centre, Darbhanga Medical College and Hospital (DMCH), Darbhanga, and continued their anti-TB drugs at home blocks were followed till their treatment outcome was known. Data were analyzed by statistical experts of DMCH. Results: Treatment supporters comprised 688 (62.83%) females and 407 (37.17%) males. Different types of treatment supporters noted were accredited social health activists (ASHAs) 622 (56.80%), family members 365 (33.33%), and community health workers 108 (09.86%). Treatment outcome as transfer out was observed in 08 (1.29%), 10 (2.74%), and 13 (12.03%) cases among ASHAs, family members, and community health workers, respectively [statistically significant (p < 0.0001)]. Conclusion: ASHAs proved to be the best treatment supporters in comparison to both family members and community health workers for multi-drug resistant TB (MDR/RR-TB) patients. |
format | Online Article Text |
id | pubmed-8982631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-89826312022-04-07 Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study Giri, Om P Kumar, Abhay Giri, Vishal P Nikhil, Nishant Cureus Pulmonology Background: Drug resistant-tuberculosis (DR-TB) patients are provided universal drug susceptibility testing (UDST), anti-TB drugs for the treatment of DR-TB, nutritional support (Nikshay Poshan Yojana - the financial incentive of rupees five hundred per month for each notified DR-TB patient for the duration for which the patient is on anti-TB drugs) by the Government of India. Methods: This retrospective cohort record-based study was conducted in DR-TB patients. Some 1095 DR-TB patients who have initiated treatment at Nodal DR-TB Centre, Darbhanga Medical College and Hospital (DMCH), Darbhanga, and continued their anti-TB drugs at home blocks were followed till their treatment outcome was known. Data were analyzed by statistical experts of DMCH. Results: Treatment supporters comprised 688 (62.83%) females and 407 (37.17%) males. Different types of treatment supporters noted were accredited social health activists (ASHAs) 622 (56.80%), family members 365 (33.33%), and community health workers 108 (09.86%). Treatment outcome as transfer out was observed in 08 (1.29%), 10 (2.74%), and 13 (12.03%) cases among ASHAs, family members, and community health workers, respectively [statistically significant (p < 0.0001)]. Conclusion: ASHAs proved to be the best treatment supporters in comparison to both family members and community health workers for multi-drug resistant TB (MDR/RR-TB) patients. Cureus 2022-03-06 /pmc/articles/PMC8982631/ /pubmed/35399462 http://dx.doi.org/10.7759/cureus.22886 Text en Copyright © 2022, Giri et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Pulmonology Giri, Om P Kumar, Abhay Giri, Vishal P Nikhil, Nishant Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study |
title | Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study |
title_full | Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study |
title_fullStr | Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study |
title_full_unstemmed | Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study |
title_short | Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study |
title_sort | impact of treatment supporters on the treatment outcomes of drug resistant-tuberculosis (dr-tb) patients: a retrospective cohort study |
topic | Pulmonology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982631/ https://www.ncbi.nlm.nih.gov/pubmed/35399462 http://dx.doi.org/10.7759/cureus.22886 |
work_keys_str_mv | AT giriomp impactoftreatmentsupportersonthetreatmentoutcomesofdrugresistanttuberculosisdrtbpatientsaretrospectivecohortstudy AT kumarabhay impactoftreatmentsupportersonthetreatmentoutcomesofdrugresistanttuberculosisdrtbpatientsaretrospectivecohortstudy AT girivishalp impactoftreatmentsupportersonthetreatmentoutcomesofdrugresistanttuberculosisdrtbpatientsaretrospectivecohortstudy AT nikhilnishant impactoftreatmentsupportersonthetreatmentoutcomesofdrugresistanttuberculosisdrtbpatientsaretrospectivecohortstudy |